These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 19679276)

  • 1. Treatment of hyperkinetic movement disorders.
    Jankovic J
    Lancet Neurol; 2009 Sep; 8(9):844-56. PubMed ID: 19679276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.
    Chen JJ; Ondo WG; Dashtipour K; Swope DM
    Clin Ther; 2012 Jul; 34(7):1487-504. PubMed ID: 22749259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperkinetic movement disorder in a child treated by globus pallidus stimulation.
    Sato K; Nakagawa E; Saito Y; Komaki H; Sakuma H; Sugai K; Sasaki M; Kaido T; Nakama H; Otsuki T
    Brain Dev; 2009 Jun; 31(6):452-5. PubMed ID: 18801630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrabenazine in the treatment of hyperkinetic movement disorders.
    Kenney C; Jankovic J
    Expert Rev Neurother; 2006 Jan; 6(1):7-17. PubMed ID: 16466307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic Treatment of Extrapyramidal Hyperkinetic Movement Disorders.
    de Boer G; Alfonsius de Bie RM; Sylvain Swinnen BEK
    Curr Neuropharmacol; 2024; 22(14):2284-2297. PubMed ID: 38847380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pearls: hyperkinetic movement disorders.
    Reich SG
    Semin Neurol; 2010 Feb; 30(1):15-22. PubMed ID: 20127576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6: Movement disorders II: the hyperkinetic disorders.
    Rice JE; Thompson PD
    Med J Aust; 2001 Apr; 174(8):413-9. PubMed ID: 11346089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Deep brain stimulation for hyperkinetic movement disorders].
    Reich MM; Volkmann J
    Nervenarzt; 2014 Feb; 85(2):147-55. PubMed ID: 24452308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal ganglia, movement disorders and deep brain stimulation: advances made through non-human primate research.
    Wichmann T; Bergman H; DeLong MR
    J Neural Transm (Vienna); 2018 Mar; 125(3):419-430. PubMed ID: 28601961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders.
    Jankovic J; Clarence-Smith K
    Expert Rev Neurother; 2011 Nov; 11(11):1509-23. PubMed ID: 22014129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Movement disorders emergencies Part 2: hyperkinetic disorders.
    Robottom BJ; Factor SA; Weiner WJ
    Arch Neurol; 2011 Jun; 68(6):719-24. PubMed ID: 21670395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep brain stimulation for other tremors, myoclonus, and chorea.
    Starr PA
    Handb Clin Neurol; 2013; 116():209-15. PubMed ID: 24112895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic use of tetrabenazine].
    López Del Val LJ; López-García E; Martínez-Martínez L; Santos-Lasaosa S
    Rev Neurol; 2009 May 16-31; 48(10):523-33. PubMed ID: 19434587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced hyperkinetic movement disorders by nonneuroleptic agents.
    Zesiewicz TA; Sullivan KL
    Handb Clin Neurol; 2011; 100():347-63. PubMed ID: 21496594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep brain stimulation for the treatment of hyperkinetic movement disorders.
    di Biase L; Munhoz RP
    Expert Rev Neurother; 2016 Sep; 16(9):1067-78. PubMed ID: 27254274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug treatment of hyperkinetic movement disorders.
    Fahn S
    Semin Neurol; 1987 Jun; 7(2):192-208. PubMed ID: 3332454
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperpolarization of the subthalamic nucleus alleviates hyperkinetic movement disorders.
    Tai CH; Pan MK; Tseng SH; Wang TR; Kuo CC
    Sci Rep; 2020 May; 10(1):8278. PubMed ID: 32427942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders.
    Guay DR
    Am J Geriatr Pharmacother; 2010 Aug; 8(4):331-73. PubMed ID: 20869622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. History, applications, and mechanisms of deep brain stimulation.
    Miocinovic S; Somayajula S; Chitnis S; Vitek JL
    JAMA Neurol; 2013 Feb; 70(2):163-71. PubMed ID: 23407652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.